Hypera S.A. (OTCMKTS:HYPMY – Get Free Report) shares reached a new 52-week low during trading on Thursday . The stock traded as low as $3.06 and last traded at $3.09, with a volume of 49715 shares. The stock had previously closed at $3.20.
Hypera Stock Down 1.3 %
The company has a fifty day moving average price of $3.91 and a 200 day moving average price of $4.77.
Hypera Company Profile
Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, Max Sulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.
See Also
- Five stocks we like better than Hypera
- What Is WallStreetBets and What Stocks Are They Targeting?
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- What is the S&P 500 and How It is Distinct from Other Indexes
- Texas Instruments: The Old-School Tech Titan Still Delivering
- What is an Earnings Surprise?
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for Hypera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hypera and related companies with MarketBeat.com's FREE daily email newsletter.
